Results 1 to 10 of about 22,933 (184)

MDR Tuberculosis Treatment

Medicina (Lithuania), 2022
Juan Espinosa-Pereiro, Adrian Sánchez-Montalvá, Maria Luisa Aznar   +2 more
exaly  

ATP-binding cassette efflux transporters and MDR in cancer

Drug Discovery Today, 2023
Rajesh N Gacche
exaly  

Interventions to reduce infections caused by multidrug resistant Enterobacteriaceae (MDR-E): A systematic review and meta-analysis

Journal of Infection, 2021
Leonard Leibovici, Dafna Yahav
exaly  

Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies

Drug Resistance Updates, 2012
Laleh Amiri-Kordestani, Agnes Basseville, Karen A Kurdziel   +2 more
exaly  

Differential metabolic responses to pluronic in MDR and non-MDR cells: A novel pathway for chemosensitization of drug resistant cancers

Journal of Controlled Release, 2010
Elena V Batrakova, David Nicholls, Valery Yu Alakhov   +2 more
exaly  

On the spread and control of MDR-TB epidemics: An examination of trends in anti-tuberculosis drug resistance surveillance data

Drug Resistance Updates, 2014
Ted Cohen, Helen E Jenkins, Chunling Lu   +2 more
exaly  

Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates

Bioorganic and Medicinal Chemistry Letters, 2004
Mire Zloh, Glenn W Kaatz, Simon Gibbons   +2 more
exaly  

MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers

Pharmacological Research, 2017
Maryam A Shetab Boushehri, Alf Lamprecht   +1 more
exaly  

MDR-1, but notMDR-3gene expression, is associated with unmutated IgVHgenes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemia

Leukemia and Lymphoma, 2006
Christine Matthews, Mark A Catherwood, Martin Clynes   +2 more
exaly  

Evaluation of the MDR-MDCK cell line as a permeability screen for the blood–brain barrier

International Journal of Pharmaceutics, 2005
Jibin Li, Ismael J Hidalgo
exaly